For clinicians and patients, the practical timeline matters: CagriSema is closer to potential approval (phase 3 complete), while amycretin's phase 3 is planned for 2026
I dont know. For another sense of the stakes: Anil told me that he reached out to 150 outside researchers to find five who would speak to him, which I think shows the fear people have about losing their funding, he said in a DM
Lancet 392 , 15191529 (2018)
These products are crucial for cell proliferation, redox balancing, reactive oxygen species (ROS) scavenging and methylation reaction in the fungal cells, which allow the fungus to successfully parasitize the host cells
Integrating Epithalon into an Anti-Aging Plan To maximize the anti-aging effects of Epithalon, it can be paired with: GH secretagogues (e.g., CJC-1295, Ipamorelin) NAD+ or NMN for mitochondrial rejuvenation Melatonin to reinforce circadian rhythm support Lifestyle interventions like strength training, time-restricted eating, and stress reduction These synergistic therapies help support the full spectrum of age reversal and health optimization
But lets assume for a second that this plays out